JPH0454126A - Treating liquid and sanitary product containing the same treating liquid - Google Patents
Treating liquid and sanitary product containing the same treating liquidInfo
- Publication number
- JPH0454126A JPH0454126A JP2164528A JP16452890A JPH0454126A JP H0454126 A JPH0454126 A JP H0454126A JP 2164528 A JP2164528 A JP 2164528A JP 16452890 A JP16452890 A JP 16452890A JP H0454126 A JPH0454126 A JP H0454126A
- Authority
- JP
- Japan
- Prior art keywords
- solution
- treating liquid
- skin
- therapeutic
- chitosan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 30
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 40
- 229920001661 Chitosan Polymers 0.000 claims abstract description 22
- 238000011282 treatment Methods 0.000 claims abstract description 18
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000004021 humic acid Substances 0.000 claims abstract description 15
- 239000002537 cosmetic Substances 0.000 claims abstract description 11
- 230000001256 tonic effect Effects 0.000 claims abstract description 9
- 206010012438 Dermatitis atopic Diseases 0.000 claims abstract description 4
- 201000008937 atopic dermatitis Diseases 0.000 claims abstract description 4
- 231100000397 ulcer Toxicity 0.000 claims abstract description 3
- 208000025865 Ulcer Diseases 0.000 claims abstract 2
- 230000001225 therapeutic effect Effects 0.000 claims description 25
- 239000003814 drug Substances 0.000 claims description 8
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- 229940124597 therapeutic agent Drugs 0.000 claims description 3
- 206010040880 Skin irritation Diseases 0.000 claims description 2
- 239000002453 shampoo Substances 0.000 claims description 2
- 230000036556 skin irritation Effects 0.000 claims description 2
- 231100000475 skin irritation Toxicity 0.000 claims description 2
- 230000008961 swelling Effects 0.000 claims description 2
- 206010042674 Swelling Diseases 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 150000002337 glycosamines Chemical class 0.000 abstract description 9
- 201000004624 Dermatitis Diseases 0.000 abstract description 4
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 abstract 1
- 206010012442 Dermatitis contact Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010030113 Oedema Diseases 0.000 abstract 1
- 208000010247 contact dermatitis Diseases 0.000 abstract 1
- 229940014797 cosamin Drugs 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 229960000583 acetic acid Drugs 0.000 description 11
- 230000000694 effects Effects 0.000 description 7
- 235000015961 tonic Nutrition 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- 239000012362 glacial acetic acid Substances 0.000 description 5
- 230000003779 hair growth Effects 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 239000000919 ceramic Substances 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 239000000693 micelle Substances 0.000 description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000006196 deacetylation Effects 0.000 description 2
- 238000003381 deacetylation reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000594592 Lanugo Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- -1 aromatic amino acids Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000000850 deacetylating effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
（イ）産業上の利用分野
本発明は、皮膚の治療薬、養毛削成いは化粧品の基剤等
に利用できる治療液及びその治療液を含有するサニタリ
ー製品に関する。Detailed Description of the Invention (a) Field of Industrial Application The present invention relates to a therapeutic liquid that can be used as a skin treatment, hair removal agent, cosmetic base, etc., and sanitary products containing the therapeutic liquid. .
（ロ）従来の技術
従来、皮膚の炎症、養毛剤等の治療に、蟹の甲羅から抽
出したキトサンが効くことが知・られており、かかるキ
トサンを利用した治療液としては、例えば、特開平１−
２１１５２９号或いは特開平１−２５４６１４号等に開
示されたものがある。(B) Conventional technology It has been known that chitosan extracted from crab shells is effective in treating skin inflammation and hair growth agents. −
There are those disclosed in No. 211529 or Japanese Patent Application Laid-Open No. 1-254614.
まず、特開平１−２１１５２９号は、クエン酸等に水を
加え、さらに、その溶液内に、キトサン粉を溶解した高
粘液を加えたものであり、健胃編集、健康食品、養毛剤
に利用されている。First, JP-A No. 1-211529 discloses a solution in which water is added to citric acid, etc., and a highly viscous liquid containing chitosan powder dissolved therein is added, and the product is used in stomach health editing, health foods, and hair tonics. ing.
一方、特開平１−２５４６１４号は、トウガラシチンキ
等の刺激性生薬を醗酵させるとともに、この中に水溶性
キトサン含有させて、養毛剤としている。On the other hand, in JP-A-1-254614, a stimulating herbal medicine such as capsicum tincture is fermented and water-soluble chitosan is contained therein to produce a hair tonic.
そして、養毛剤は、刺激性生薬によって、頭部の皮膚の
血行を促進して、育毛効果を有するものである。The hair tonic is a stimulating herbal medicine that promotes blood circulation in the skin of the head and has a hair growth effect.
（ハ）発明が解決しようとする課題
ところが、上記の薬剤は、以下のような欠点を有してい
る。(c) Problems to be Solved by the Invention However, the above-mentioned drugs have the following drawbacks.
即ち、この薬剤の原料たるクエン酸等は、悪臭を発生す
る欠点を有し、特に、身体の皮膚或いは頭部の皮膚に塗
布した際に、その周りに不快感を与えるものであった。That is, citric acid and the like, which are raw materials for this drug, have the disadvantage of generating a bad odor, and especially when applied to the skin of the body or the skin of the head, it gives a feeling of discomfort to the surrounding area.
また、他のものは、刺激性生薬によって、キトサンの薬
効成分が分解し、その効き目を低下させて、効果的な育
毛を促すことができないものであった。In addition, in other products, the medicinal components of chitosan are degraded by irritating herbal medicines, reducing its effectiveness and making it impossible to promote effective hair growth.
本発明は、上記の課題を解決することができる治療液を
提供することを目的とする。An object of the present invention is to provide a therapeutic solution that can solve the above problems.
（ニ）課題を解決するための手段
本発明では、酢酸溶液中に、キトサンを溶解するととも
もに、同溶液中にフミン酸を混入したことを特徴とする
治療液を提供するものである。(d) Means for Solving the Problems The present invention provides a therapeutic solution characterized by dissolving chitosan in an acetic acid solution and mixing humic acid into the same solution.
また、本発明では、上記の治療液を、アトピー性皮膚炎
、被れ、腫れ、潰瘍等を治療する皮膚用治療薬としだを
特徴としている。Further, in the present invention, the above-mentioned therapeutic liquid is characterized as a skin therapeutic agent for treating atopic dermatitis, skin irritation, swelling, ulcers, and the like.
また、本発明では、上記の治療液を、養毛剤としたこと
を特徴としている。Further, the present invention is characterized in that the above-mentioned treatment liquid is a hair tonic.
また、本発明では、上記の治療液を、飲用する内服薬と
したことをを特徴としている。Further, the present invention is characterized in that the above-mentioned therapeutic liquid is used as an internal medicine to be taken.
さらに、本発明では、上記の治療液を、化粧品、入浴剤
、シャンプー、リンス等のサニタリー製品に混入したこ
とを特徴する治療液を含有するサニタリー製品を提供す
るものである。Furthermore, the present invention provides a sanitary product containing a therapeutic liquid characterized in that the above-mentioned therapeutic liquid is mixed into sanitary products such as cosmetics, bath salts, shampoos, and conditioners.
（ホ）作用及び効果
本発明では、酢酸溶液中に、キトサンを溶解する際に、
キトサンがグルコサミンというアミノ糖に加水分解され
、このアミノ糖が皮膚等を治癒するものである。(e) Actions and Effects In the present invention, when dissolving chitosan in an acetic acid solution,
Chitosan is hydrolyzed into an amino sugar called glucosamine, and this amino sugar heals the skin.
即ち、キトサン中のアミノ糖が破壊された皮膚の機能を
回復させることにより、皮膚が生殖されて、皮膚の炎症
を直したり、頭部より毛髪を育成させることができる。That is, the amino sugar in chitosan restores the functions of the destroyed skin, thereby regenerating the skin, curing skin inflammation, and allowing hair to grow from the head.
また、フミン酸は、酢酸溶液から発する悪臭を消すこと
により、治療液の使用を容易にすることができる。Humic acid can also make the treatment solution easier to use by eliminating the bad odor emanating from the acetic acid solution.
しかも、酢酸溶液中に、フミン酸を混入することにより
、キトサン中のアミノ糖をそのままの状態で保持して、
この溶液を安定化させ、キトサンによる効果を保つこと
ができる。Moreover, by mixing humic acid into the acetic acid solution, the amino sugars in chitosan can be maintained as they are,
This solution can be stabilized and the effects of chitosan can be maintained.
さらに、上記の治療液を、化粧品の基剤又は入浴剤とし
て使用した場合、化粧品による肌荒れ等の問題を解消し
て、安全に使用することができ、さらに、肌への治療効
果を得ることができる。Furthermore, when the above-mentioned treatment liquid is used as a base for cosmetics or as a bath additive, it can eliminate problems such as rough skin caused by cosmetics and can be used safely, and furthermore, it can provide therapeutic effects on the skin. can.
このように、本発明によれば、フミン酸により酢酸等か
ら放つ悪臭を消し、その使用を容易に行うことができ、
さらに、キトサンの薬効効果を保持することができる。As described above, according to the present invention, humic acid can eliminate the bad odor emitted from acetic acid, etc., and its use can be easily carried out.
Furthermore, the medicinal effects of chitosan can be retained.
（へ）実施例
本発明の実施例を図面ムこもとづき詳説すれば、酢酸容
液中に、蟹の甲羅から抽出したキトサンと、フミン酸と
を混入した治療液を構成している。(F) Embodiment The embodiment of the present invention will be described in detail with reference to the drawings. A treatment liquid is constituted by mixing chitosan extracted from crab shell and humic acid into an acetic acid solution.
即ち、本実施例では、蒸留水１ｐに、］ Ｏｃｃの氷酢
酸を混入して、よく撹拌して、かかる治療液の溶媒とな
る氷酢酸溶液を作る。That is, in this example, 1 p of distilled water is mixed with glacial acetic acid (Occ) and stirred thoroughly to prepare a glacial acetic acid solution that will serve as a solvent for the treatment solution.
そして、この氷酢酸溶液内に、脱アセチル化度８３２の
キトサン１０ｇを加えて、同溶液中にキトサンを溶解す
る。Then, 10 g of chitosan with a degree of deacetylation of 832 is added to this glacial acetic acid solution to dissolve the chitosan in the solution.
なお、このキトサンは、キチンを濃アルカリで脱アセチ
ル化して製造したものであり、脱アセチル化度が高いほ
ど、アミノ酸を多く含んでいる。Note that this chitosan is produced by deacetylating chitin with a concentrated alkali, and the higher the degree of deacetylation, the more amino acids it contains.
かかるキトサンは、氷酢酸溶液内に溶解した際に、グル
コサミンというアミノ糖に加水分解され、このアミノ糖
が荒れた皮膚等を治癒する効果を有するものである。When such chitosan is dissolved in a glacial acetic acid solution, it is hydrolyzed into an amino sugar called glucosamine, and this amino sugar has the effect of healing rough skin and the like.
さらに、本実施例では、キトサンを溶解した木酢ｆＩ！
溶液内に、２０重量％のフミン酸コロイドミセル（天然
ミネラル酵素）を混合して、よく撹拌する。Furthermore, in this example, wood vinegar fI! in which chitosan was dissolved!
20% by weight of humic acid colloid micelles (natural mineral enzyme) are mixed into the solution and stirred well.
かかるフミン酸コロイドミセルは、アミノ酸、フミン酸
、珪酸及び金属成分を含む腐植質土壌を水に混合して得
た懸濁液を一次熟成した後、固形成分を濾過した液をさ
らに二次熟成したものである。Such humic acid colloidal micelles are obtained by firstly aging a suspension obtained by mixing humic soil containing amino acids, humic acid, silicic acid, and metal components with water, and then filtering the solid components and then secondly aging the liquid. It is something.
この液は、フミン酸と、土壌微生物と、オルガノ−ゲン
元素から構成されている。This liquid is composed of humic acid, soil microorganisms, and organogen elements.
まず、フミン酸の分子には、ポリフェノールやキノン型
の芳香族アミノ酸があり、ウロン酸型の炭水化物と一緒
に結合して、芳香族の供給源としてリグニン、タンニン
及び微生物の分質代謝の産物である二次生成化合物が含
まれている。First, humic acid molecules include polyphenols and quinone-type aromatic amino acids, which are combined with uronic acid-type carbohydrates to serve as a source of aromatics, such as lignin, tannins, and products of microbial metabolization. Contains certain secondary product compounds.
また、土壌微生物は、細菌（土壌１ｇ中１００〜３００
万個）よりなっており、好気性１嫌気性がそれぞれ共存
しているものである。In addition, soil microorganisms include bacteria (100 to 300 per gram of soil).
1,000,000), with one aerobic and one anaerobic coexisting.
さらに、オルガノーゲン元素は、有機体の生活に絶対不
可欠な元素で活量的に分類すると、炭素１５χ、珪素１
７χ、酸素５χ、水素５χ及び金属元素８χ等で構成さ
れている。Furthermore, organogen elements are elements that are absolutely essential for the life of organisms, and when classified based on their activity, they include 15x carbon and 1x silicon.
7χ, oxygen 5χ, hydrogen 5χ, and metal element 8χ.
そして、フミン酸コロイドミセルは、氷酢酸溶液から放
つ悪臭を消すことができるとともに、殺菌効果をも有し
、その使用を容易に行うことができる。Humic acid colloidal micelles can eliminate the bad odor emitted from glacial acetic acid solutions, and also have a sterilizing effect, making them easy to use.
本発明の治療液は、皮膚用治療薬、養毛剤、化粧品の基
材、入浴剤等のサニタリー製品等に使用することができ
、各使用方法及びその結果について詳説する。The therapeutic solution of the present invention can be used in skin therapeutics, hair tonics, base materials for cosmetics, sanitary products such as bath salts, etc. Each method of use and its results will be explained in detail.
■皮膚用治療薬
上記の治療液をガーゼ等に染み込ませ、荒れた皮膚の患
部に、治療液を塗布する皮膚用治療剤として使用する。■Treatment for the skin The above treatment liquid is soaked in gauze, etc., and used as a treatment for the skin by applying the treatment liquid to the affected area of rough skin.
そして、本発明の皮膚用治療薬は、火傷、荒れた皮膚、
アトピー性皮膚炎等に効果がある。The skin therapeutic agent of the present invention can treat burns, rough skin,
Effective for atopic dermatitis, etc.
そこで、皮膚炎の患者２０人を対象として、１日２〜３
回約４週間この治療液を患部に塗布し、その結果を示す
。Therefore, we targeted 20 patients with dermatitis and tested 2 to 3 times a day.
This treatment solution is applied to the affected area for about 4 weeks and the results are shown.
・１８人の患者の患部が完治した。- The affected areas of 18 patients were completely healed.
・２人の患者の患部に薄い皮膚ができた。・Two patients developed thin skin on the affected area.
■養毛剤
上記の治療液をガーゼ等に染み込ませ、頭部に、塗布す
る養毛剤として使用する。■Hair tonic Use the above treatment solution as a hair tonic by soaking it into gauze or the like and applying it to the head.
そこで、２０人を対象として、１日２〜３回約４週間〜
８週間この養毛剤を頭部に塗布し、その結果を示す。Therefore, for 20 people, 2 to 3 times a day for about 4 weeks ~
This hair growth agent was applied to the head for 8 weeks, and the results are shown below.
・１６人の頭部から黒髪が生えてきた。-Black hair grew from the heads of 16 people.
・３人の頭部から産毛が生えてきた。・Lanugo hair has grown from the heads of three people.
第２表
■化粧品
上記の治療液を基剤としてサニタリー製品としての化粧
品とする場合、この基剤中に、油及びアルコール等を混
入して、化粧品とする。Table 2 - Cosmetics When making cosmetics as sanitary products using the above treatment liquid as a base, oil, alcohol, etc. are mixed into this base to make cosmetics.
本実施例では、化粧品として、化粧水及びクリームにつ
いて第１表及び第２表にその成分を示す。In this example, Tables 1 and 2 show the ingredients of lotions and creams as cosmetics.
第１表
そして、上記の化粧水及びクリームを肌につけると、皮
膚用治療薬と同様の効果を得ることができる。Table 1 When the above-mentioned lotions and creams are applied to the skin, the same effects as skin treatments can be obtained.
■その他のサニタリー製品
次いで、上記の治療液を、入浴剤、ンヤンブーリンス等
のサニタリー製品に混入した場合について、その成分を
第３表〜第５表にそれぞれ示す。(2) Other sanitary products Next, Tables 3 to 5 show the components of sanitary products such as bath salts and Nyanbu rinse when the above-mentioned therapeutic liquid is mixed into the sanitary products.
第３表
第５表
また、本発明の治療液を、そのまま浴場中に投入しても
よく、その際に、この治療液によって荒れた肌を治癒す
ることができる。Table 3 Table 5 Furthermore, the therapeutic liquid of the present invention may be directly poured into a bath, and in this case, rough skin can be healed by this therapeutic liquid.
さらに、本発明では、上記のように製造された治療液に
、遠赤外線を放出するセラミック等を混入して、同遠赤
外線によって、治療液の効果を高めるようにしている。Furthermore, in the present invention, a ceramic or the like that emits far infrared rays is mixed into the therapeutic liquid produced as described above, so that the effect of the therapeutic liquid is enhanced by the far infrared rays.
本実施例では、ペレット状としたセラミックス第４表
を混入して、その表面から遠赤外線を放出し、治療液中
の水に、遠赤外線を照射し、水の性質を変えるようにし
ている。In this example, pelletized ceramics Table 4 are mixed in, and far infrared rays are emitted from the surface thereof, and the water in the treatment liquid is irradiated with far infrared rays to change the properties of the water.
即ち、遠赤外線によって、水の分子を高密度として、治
療液の薬効性を高めるものである。That is, far infrared rays make water molecules highly dense, thereby increasing the medicinal efficacy of the therapeutic solution.
また、他の実施例として、遠赤外線を放出するセラミッ
ク等によって、容器を形成し、同容器内に治療液を収納
し、容器からの遠赤外線を治療液に照射することも可能
としている。In another embodiment, a container may be formed of ceramic or the like that emits far infrared rays, a therapeutic liquid may be stored in the container, and the far infrared rays from the container may be irradiated onto the therapeutic liquid.
Claims (1)
液中にフミン酸を混入したことを特徴とする治療液。 ２、上記の治療液を、アトピー性皮膚炎、被れ、腫れ、
潰瘍等を治療する皮膚用治療薬としたことを特徴とする
請求項１に記載の治療液。 ３、上記の治療液を、養毛剤としたことを特徴とする請
求項１に記載の治療液。 ４、上記の治療液を、飲用する内服薬としたことを特徴
とする請求項１に記載の治療液。５、上記の治療液を、
化粧品、入浴剤、シャンプー、リンス等のサニタリー製
品に混入したことを特徴とする治療液を含有するサニタ
リー製品。[Claims] 1. A therapeutic solution characterized by dissolving chitosan in an acetic acid solution and mixing humic acid into the same solution. 2. Use the above treatment solution for atopic dermatitis, skin irritation, swelling,
The therapeutic liquid according to claim 1, which is used as a skin therapeutic agent for treating ulcers and the like. 3. The therapeutic solution according to claim 1, wherein the therapeutic solution is a hair tonic. 4. The therapeutic solution according to claim 1, wherein the therapeutic solution is an internal medicine to be taken. 5. The above treatment solution,
Sanitary products containing therapeutic fluids that are characterized by being mixed into sanitary products such as cosmetics, bath salts, shampoos, and conditioners.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2164528A JPH0454126A (en) | 1990-06-21 | 1990-06-21 | Treating liquid and sanitary product containing the same treating liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2164528A JPH0454126A (en) | 1990-06-21 | 1990-06-21 | Treating liquid and sanitary product containing the same treating liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0454126A true JPH0454126A (en) | 1992-02-21 |
Family
ID=15794883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2164528A Pending JPH0454126A (en) | 1990-06-21 | 1990-06-21 | Treating liquid and sanitary product containing the same treating liquid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0454126A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0730867A2 (en) * | 1995-03-09 | 1996-09-11 | RES PHARMA S.r.l. | Non-animal polyanions for use in dermatology and cosmetics |
| WO1998052576A1 (en) * | 1997-05-21 | 1998-11-26 | New Key Foods N.V. | Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain |
| WO2006092908A1 (en) * | 2005-02-28 | 2006-09-08 | University Of Tsukuba | Type i allergy inhibitor and methods of inhibiting the onset of type i allergy using fulvic acid |
| JP2019127478A (en) * | 2018-01-25 | 2019-08-01 | 国立大学法人鳥取大学 | Hair growth and hair restoration enhancer |
-
1990
- 1990-06-21 JP JP2164528A patent/JPH0454126A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0730867A2 (en) * | 1995-03-09 | 1996-09-11 | RES PHARMA S.r.l. | Non-animal polyanions for use in dermatology and cosmetics |
| EP0730867A3 (en) * | 1995-03-09 | 1997-01-08 | Res Pharma Srl | Non-animal polyanions for use in dermatology and cosmetics |
| WO1998052576A1 (en) * | 1997-05-21 | 1998-11-26 | New Key Foods N.V. | Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain |
| US6495531B2 (en) * | 1997-05-21 | 2002-12-17 | New Key Foods N. V. | Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain |
| WO2006092908A1 (en) * | 2005-02-28 | 2006-09-08 | University Of Tsukuba | Type i allergy inhibitor and methods of inhibiting the onset of type i allergy using fulvic acid |
| JP2019127478A (en) * | 2018-01-25 | 2019-08-01 | 国立大学法人鳥取大学 | Hair growth and hair restoration enhancer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Burlando et al. | Honey in dermatology and skin care: a review | |
| RU2471492C2 (en) | Electrogenerating particles and use thereof | |
| JP4889093B2 (en) | Sponge-based therapeutic compositions for the treatment and prevention of skin diseases | |
| CA2125190A1 (en) | Skin therapeutic mixture containing cold-processed aloe vera extract, with yellow sap and aloin removed | |
| HUP0102899A2 (en) | Process for preparation of compositions for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract | |
| HU229230B1 (en) | Medical composition for the treatment of herpes simplex virus and other infectious diseases | |
| UA41989C2 (en) | Pharmaceutical composition in form of gel for treating skin diseases and method for treating infected skin | |
| JP2021050249A (en) | Formulations containing pomegranate seed oil, rosa canina fruit oil and inula viscosa oleoresin or extract | |
| KR20070089474A (en) | Cosmetic composition for controlling anti-acne and anti-comedo | |
| CA2882392A1 (en) | Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne | |
| CN108379189A (en) | A kind of face cream and preparation method thereof | |
| RU2166309C1 (en) | Treatment-and-prophylactic and cosmetic composition | |
| JPH0454126A (en) | Treating liquid and sanitary product containing the same treating liquid | |
| CN109498535A (en) | Bacteria inhibiting composition, antibacterial disposable gel and its preparation method and application | |
| CN105169463B (en) | A kind of cation baby's medical dressing and preparation method thereof | |
| KR102293585B1 (en) | Wax-type cleanser | |
| RU2577950C1 (en) | Method of stimulating healing dermal burns | |
| EP1663195B1 (en) | Taurine bromamine for inhibiting pathogenic bacteria and fungi growth as well as in a microbicidal composition | |
| CA2132170A1 (en) | Medicine for the treatment of alopecia and skin diseases | |
| CN107595819B (en) | A kind of Nano diamond modified liquid adhesive bandage and preparation method thereof | |
| JPH0977665A (en) | Skin liniment | |
| KR102329748B1 (en) | Wax-type cleanser improving problematic skin | |
| JPH04334321A (en) | Preventive for dermatic inflammation | |
| JP2004189676A (en) | External preparation for ameliorating damaged skin | |
| CN1082372C (en) | Liquid medicine for treatment of bromidrosis, and its preparing method |